230 related articles for article (PubMed ID: 35092215)
1. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope.
He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD
Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215
[TBL] [Abstract][Full Text] [Related]
2. Myocardial reperfusion injury: looking beyond primary PCI.
Fröhlich GM; Meier P; White SK; Yellon DM; Hausenloy DJ
Eur Heart J; 2013 Jun; 34(23):1714-22. PubMed ID: 23536610
[TBL] [Abstract][Full Text] [Related]
3. Translation of experimental cardioprotective capability of P2Y
Hjortbak MV; Olesen KKW; Seefeldt JM; Lassen TR; Jensen RV; Perkins A; Dodd M; Clayton T; Yellon D; Hausenloy DJ; Bøtker HE;
Basic Res Cardiol; 2021 May; 116(1):36. PubMed ID: 34037861
[TBL] [Abstract][Full Text] [Related]
4. Reperfusion in STEMI patients: still a role for cardioprotection?
Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
[TBL] [Abstract][Full Text] [Related]
5. Conditioning the heart to prevent myocardial reperfusion injury during PPCI.
Hausenloy DJ
Eur Heart J Acute Cardiovasc Care; 2012 Apr; 1(1):13-32. PubMed ID: 24062884
[TBL] [Abstract][Full Text] [Related]
6. Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
Engstrøm T; Nepper-Christensen L; Helqvist S; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamaki K; Tilsted HH; Steensberg A; Fabricius S; Mouritzen U; Vejlstrup N; Ahtarovski KA; Göransson C; Bertelsen L; Kyhl K; Olivecrona G; Kelbæk H; Lassen JF; Køber L; Lønborg J
Heart; 2018 Oct; 104(19):1593-1599. PubMed ID: 29602883
[TBL] [Abstract][Full Text] [Related]
7. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
Heusch G; Gersh BJ
Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
[TBL] [Abstract][Full Text] [Related]
9. The effects of remote ischemic conditioning in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a meta-analysis.
Gao J; Chen Q; Liu F; Zhao Q; Chen B; Zhou Y; Zhao Q; Ma Y; Yang Y
Minerva Med; 2017 Aug; 108(4):370-380. PubMed ID: 28217986
[TBL] [Abstract][Full Text] [Related]
10. Reducing myocardial infarct size: challenges and future opportunities.
Bulluck H; Yellon DM; Hausenloy DJ
Heart; 2016 Mar; 102(5):341-8. PubMed ID: 26674987
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
12. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
Hausenloy DJ; Garcia-Dorado D; Bøtker HE; Davidson SM; Downey J; Engel FB; Jennings R; Lecour S; Leor J; Madonna R; Ovize M; Perrino C; Prunier F; Schulz R; Sluijter JPG; Van Laake LW; Vinten-Johansen J; Yellon DM; Ytrehus K; Heusch G; Ferdinandy P
Cardiovasc Res; 2017 May; 113(6):564-585. PubMed ID: 28453734
[TBL] [Abstract][Full Text] [Related]
13. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
[TBL] [Abstract][Full Text] [Related]
14. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).
Siddiqi N; Bruce M; Neil CJ; Jagpal B; Maclennon G; Cotton SC; Papadopoulo SA; Bunce N; Lim P; Schwarz K; Singh S; Hildick-Smith D; Horowitz JD; Madhani M; Boon N; Kaski JC; Dawson D; Frenneaux MP
J Transl Med; 2013 May; 11():116. PubMed ID: 23648219
[TBL] [Abstract][Full Text] [Related]
15. Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.
Song L; Yan H; Zhou P; Zhao H; Liu C; Sheng Z; Tan Y; Yi C; Li J; Zhou J
Clin Cardiol; 2018 Aug; 41(8):997-1003. PubMed ID: 29726013
[TBL] [Abstract][Full Text] [Related]
16. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI).
Siddiqi N; Neil C; Bruce M; MacLennan G; Cotton S; Papadopoulou S; Feelisch M; Bunce N; Lim PO; Hildick-Smith D; Horowitz J; Madhani M; Boon N; Dawson D; Kaski JC; Frenneaux M;
Eur Heart J; 2014 May; 35(19):1255-62. PubMed ID: 24639423
[TBL] [Abstract][Full Text] [Related]
17. Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.
Li J; Sun D; Li Y
Curr Pharm Des; 2019; 25(35):3726-3739. PubMed ID: 31692431
[TBL] [Abstract][Full Text] [Related]
18. Promising strategies to minimize reperfusion injury in STEMI.
Bulluck H; Yellon RL; Yellon DM
Minerva Cardioangiol; 2016 Jun; 64(3):284-94. PubMed ID: 26859232
[TBL] [Abstract][Full Text] [Related]
19. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial.
Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E
BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532
[TBL] [Abstract][Full Text] [Related]
20. Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction.
Pryds K; Terkelsen CJ; Sloth AD; Munk K; Nielsen SS; Schmidt MR; Bøtker HE;
Heart; 2016 Jul; 102(13):1023-8. PubMed ID: 26911520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
